Nighttime outdoor artificial light may increase risk of age-related macular degeneration
January 19th 2024A new case-control study found that older people ages 70 and older living in South Korea’s urban areas were at a significantly higher risk for developing incident exudative age-related macular degeneration.
Morrow, Novacel Optical partner in preparation of eProgressive smart glasses launch
January 18th 2024The European companies are collaborating in part of a strategic distribution partnership before the eProgressive smart glasses are available to the public later this year. The smart glasses use switchable lens technology to provide ease and comfort to patients needing progressive lenses.
Pupillometry responses may be a valuable biomarker of depression
January 16th 2024A collaborative study has found that pupillometry as a clinical test may help identify biomarkers for major depressive disorder. The test identifies a subgroup of patients with anticipatory hypo-arousal subserving anhedonia symptomatology.
Vietnam's Pediatric Refractive Error Training Center prepares students amid growing myopia cases
January 16th 2024Robert Weiss, former president and CEO of The Cooper Companies, shares some of the latest optometric schooling developments from Vietnam in his work with Optometry Giving Sight, the Brian Holden Foundation, and Hanoi Medical University.
Diplopia in concussion – what is normal? What is abnormal, and when should it go away?
January 15th 2024New developments to progress diagnostic criteria for Mild Traumatic Brain Injury (TBI) are discussed by The Mild Traumatic Brain Injury (TBI) Task Force of the American Congress of Rehabilitation Medicine Brain Injury Special Interest Group.
Adjunct role for Dextenza insert in allergic conjunctivitis?
January 8th 2024Regarding both the amount and speed of symptom improvement, patients were more satisfied with the insert compared with the topical steroid, but there was no statistically significant difference vs the topical antihistamine in terms of satisfaction.